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1. Introduction  
One of the key issues in studying organogenesis is to understand the mechanisms 
underlying the differentiation of progenitor cells into more specialized cells of individual 
tissue. The formation and regeneration of each tissue is associated with a cascade of signals 
involving a sequential activation of successive genes in response to transcriptional 
regulators, growth factors, cytokines and hormones. Mediators such as fibroblast growth 
factor (FGF), transforming growth factor beta (TGF-), insulin-like growth factors (IGF) and 
many other proteins influence the early stage of cell and tissue formation. The factors are 
not tissue-specific and control the proliferation and differentiation of most cell types. The 
proper tissue formation, maturation and function is controlled by factors unique to 
particular tissue. 
Transcriptional regulation is the most important step controlling the decision which genes 
will be expressed at a given time, thus affect the fate of cells. The recent progress in 
molecular biology, animal models and development of the skeletal phenotype induced by 
genetic mutations in humans, led to a better understanding of the role of transcriptional 
factors that govern bone formation and are specifically activated during osteogenesis. 
The development of the vertebrate skeletal elements may take place through two different 
mechanisms: osteoblastogenesis and osteochondrogenesis, and relies on the differentiation 
of the required cell types: osteoblasts and chondrocytes (membranous and 
endochondral/cartilaginous osteogenesis, respectively), which are derived from common 
mesenchymal stem cells (Fig. 1.).  
Osteoblastogenesis (membranous osteogenesis) takes place in the mesenchymal membrane, 
where osteoblast progenitor cells differentiate directly from embryonic condensed 
mesenchyme, mature to osteoblasts and begin to secrete type I collagen, proteoglycans and 
intercellular substance of the organic component of bone – osteoid. These mechanisms are 
responsible for the development of skull bones, facial bones and parially colarbone. 
Most of the vertebrate skeleton develops through endochondral ossification, whereby a 
cartilaginous template is initially formed and subsequently mineralized and replaced bone. 
Endochondral bone formation (cartilaginous osteogenesis) takes place in long bones starting 
with the condensation of skeletal precursors, proceeding to the formation of a cartilagenous 
template. Chondrocytes at the condensation centre stop proliferating and become 
hypertrophic (enlarged). This process induces differentiation of osteoblast precursors in the 
perichondrium adjacent to the region of hypertrophic cells. Perichondrial cells adjacent to 
hypertrophic chondrocytes become osteoblasts, forming bone collar. At the subsequent steps 






Vascular invasion follows, bringing osteoblast progenitors from the bone collar into the 
centre of the future bone. Chondrocytes continue to proliferate, lengthening the bone. 
Osteoblasts of primary spongiosa are precursors of eventual trabecular bone; osteoblasts of 
bone collar become cortical bone. At the end of the bone, the secondary ossification centre 
forms through cycles of chondrocyte hypertrophy, vascular invasion and osteoblast activity. 
A bone marrow expands in marrow space along with stromal cells.  
 
 
Fig. 1. Schematic representation of membranous and endochondral bone formation. A - 
mesenchymal cells condensation and proliferation; B – differentiation; C – production of 
mature osteoblasts; D – osteoblast differente into osteocytes,blood vessels invade and 
together with osteoblast start to make bone utilize the mineralized matrix; E – synthesis of 
extracellular matrix and chondrocytes grow to become hypertrophic; F – apoptosis of 
hypertrophic chondrocytes and osteoblast invasion; G – vascularization of cartilage and 
osteoblast maturation, secondary ossification center formation are not shown. 
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All of phenotypic and physiological changes in mesenchymal cells arise as a result of 
regulatory events at the genetic level. Mutations or deregulation of these processes lead to 
skeletal malformation, and/or susceptibility to injury. Over the past years on the basis of in 
vivo and in vitro studies various transcription factors have been identified that play 
important roles for skeletal formation being either active in osteoblasts and chondrocytes or 
in both cell types. The molecular mechanisms controlling the chondrogenic and osteogenic 
program are becoming elucidated; however, major difficulty in the overall understanding of 
bone formation is to combine all scattered pieces of information considering the function 
and importance of individual genes and their products into comprehensive signal network. 
This chapter presents recent findings on the role of the most important and unique genetic 
regulators supporting bone formation.  
2. Transcription control of osteoblastogenesis 
The specific structure of bone, its function and metabolism are a result of the processes of 
bone formation, resorption, mineral homeostasis and bone regeneration. Osteoblasts are 
bone-forming cells that synthesize and mineralize extracellular matrix. In membranous bone 
formation, they arise from multipotential mesenchymal stem cells under the influence of 
growth factors, hormones and cytokines. Differentiation of progenitor cells into osteoblast in 
vitro has been induced by the presence of osteogenic supplements in cultured medium 
(dexamethasone, ascorbic acid, vitamin D3, β-glycerophosphate). The proper maturation 
and osteoblast function is directly related to the expression of two key transcription factors 
of osteoblastogenesis: Runx2 and Osterix. 
2.1 Runx2 (Runt-related transcription factor 2) 
The transcriptional control of the proliferation, growth and differentiation of mesenchymal 
stem cells into mature bone cells is primarily controlled by Runx2 (also known as CBFA1, 
AML3 or OSF2). Numerous in vitro studies have shown that Runx2 is a positive regulator of 
gene expression, whose products are bone extracellular matrix proteins, such as type I 
collagen, osteopontin, bone sialoprotein and osteocalcin (Komori, 2006). Runx2 is frequently 
described as the master regulator of osteoblastogenesis. Its deficiency in homozygots leads 
to different types of bone dysplasia, consisting of genetically determined disorders in the 
structure of the skeleton (Marie, 2008). Runx2 is also involved in processes related to the 
maturation of cartilage cells (Makita et al., 2008). However, during dentinogenesis, Runx2 
expression is downregulated, and Runx2 inhibits the terminal differentiation of odontoblast. 
Runx2 expression has also been recently demonstrated in non-skeletal tissues such as breast, 
brain, sperm and T cells (Leong et al., 2009). Therefore, it may play a role in transmitting 
epigenetic information encoded in DNA. The mechanism for regulating the expression of 
genetic information by Runx2 has been intensively studied for many years. Runx2 is a DNA-
binding transcriptional factor that interacts with the promoters of specific target genes 
through the Runt domain. Its potential binding site has been identified at target promoters, 
for example in the promoter region of sialoproteins between position -84 to -79 and -184 to -
179 relative to the transcription start point (Paz et al., 2005). Regions recognized by Runx2 
demonstrate a consensus sequence (PuACCPuCa) described as an osteoblast specific 
element (OSE2). Runx2 belongs to the Runt family. It should be noted that the other two 
regulators of the Runt family, Runx1 and Runx3, also participate in the induction of 
osteoblastic genes. Amino acid sequence alignments of all main Runt family proteins are 







Fig. 2. Amino acid sequence alignments of human Runt family transcriptional regulators: 
Runx1, Runx2 and Runx3. Residues conserved are colored in red and marked with a star. 
The dots indicate amino acids with very similar properties. Green bar below the sequence 
alignment represents DNA binding motif - Runt domain. Sequence accession numbers: 
Q01196, Q13950, Q13761, respectively. 
Two distinct mechanisms involving osteoblast-mediated membranous and endochondrial 
ossification have been proposed: Runx1 participates in membranous bone formation which 
corresponds to the involvement of this protein in the early stages of osteoblastogenesis, 
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while Runx2 plays an exclusive role in both membranous and endochondral bone forming 
processes that is in the process of osteoblast maturation. Runx3 is engaged in the 
differentiation of chondrocytes in cartilaginous ossification. The Runt family regulators are 
proteins that have transcription isoforms. Three isoforms of Runx2 protein are a result of 
complex process of alternative splicing (Li & Xiao, 2007). However, the specific molecular 
mechanism involved in the potential isoform functions in bone formation are not well 
understood. Positive transcription regulators of Runx2 were identified earlier (bone 
morphogenetic proteins, homeodomain proteins), while the first reports of proteins that 
inhibit Runx2 gene expression were published in 2009, when the Nieto group showed Snail1 
to be a transcriptional repressor at the Runx promoters. Snail1 is a protein involved in the 
transformation of epithelial cells in the development of embryonic mesenchymal cells (EMT, 
called the epithelial mesenchymal transition) (De Frutos et al., 2009). Another repressor of 
Runx2 is Twist - basic helix-loop-helix transcription factor that regulates differentiation of 
multiple cell types. Twist inhibits osteoblastogenesis by interaction with Runx2-DNA 
binding domain and in this way prevents its ability to bind DNA (Bialek et al., 2004). 
Expression of Runx2 is controlled by Foxo1 which can also directly interact with this 
transcription factors. Teixeira and coworkers suggested that Foxo1 is an early molecular 
regulator during mesenchymal cell differentiation into osteoblast exerting its effects through 
regulation and interaction with Runx2 (Teixeira et al., 2010). 
Several studies have indicated that Runx2 is a context-dependent transcriptional activator 
and repressor and may interact with other regulatory proteins, suggesting a complex 
mechanism of osteoblastogenesis control by this factor. So far coactivators of a Runx2-
dependent transcription include p300 and CBP (CREB-binding protein), which function as 
transcriptional adapters in interactions with other proteins in multiprotein regulatory 
complexes. Through direct interaction with Runx2, they up-regulate Runx2-dependent 
transcription. Runx2 corepressors are components of multiprotein complexes that mediate 
histone deacetylation and condensation of chromatin, such as the TLE (transducin-like 
enhancer), mSin3A and HDAC3/4/6. Runx2 interacts with many transcription factors, such 
as Smad1 and Smad5, Twist, Dlx family, Zfp521. The nature of this cooperation is of great 
interest to many research teams. 
The functional activity of Runx2 is particularly sensitive to posttranslational modification of 
the protein (e.g. phosphorylation, acetylation, methylation). It seems that the preferred 
interaction of Runx2 with specific cofactors depends on its post-translational modifications 
(Bae & Lee, 2006). Although Runx2 and its impact on osteoblast differentiation has been 
widely accepted, our knowledge on the mechanism underlying the process and factors 
influencing Runx2 expression or activity still require further studies. 
2.2 Osterix 
Osterix (SP7, OSX) is another transcriptional regulator, essential for differentiation of 
progenitor cells into osteoblasts, and hence for bone formation. This protein belongs to the 
Sp/XKLF family of transcriptional factors. The common feature of these regulators is the 
presence of a DNA binding domain, consisting of Cys2His2 zinc fingers. The OSX protein is 
comprised of 431 amino acids and contains three zinc finger motifs located in the C-terminal 
part. It is also possible to distinguish a proline- and serine-rich activation domain between 
141 and 210 amino acids. Osterix transcription is positively regulated by Runx2, and in 






osteoblast-specific regulator and its activity has not yet been demonstrated in other cell 
types. The expression of early markers of osteoblast differentiation (e.g. osteopontin, 
alkaline phosphatase) in the human osteosarcoma cell line MG63 is not dependent on 
Osterix (Hatta et al., 2006). In contrast, the activation of late genes, such as osteocalcin, is 
correlated with the presence of this regulator; thus, it appears that Osterix is a factor 
required to progress the differentiation of preosteoblasts into mature osteoblasts. Despite its 
involvement in osteoblast differentiation, Osterix regulatory mechanism is not fully 
understood yet. Osterix activation region is known to interact with many regulatory 
proteins, including NFAT (nuclear factor of activated T cell) and primary transcription 
factor – TF-IIB, or Brg1 – chromatin-remodeling factor. Using matrix-assisted laser 
desorption ionization time-of-flight mass spectrometry, novel Osterix-interacting factors 
have been identified, such as RNA helicase A (RHA) (Amorim et al., 2007). 
Immunoprecipitation and Western blot analysis has shown Osterix to directly associate with 
RNA helicase A. Hence, RNA helicase A may act as a component in Osterix regulation of 
osteoblast differentiation. Osterix activity is regulated by various post-translational 
modifications including phosphorylation and glycosylation (Chu & Ferro, 2005). It has been 
shown that calcineurin, a protein phosphatase, affects the function of Osterix through direct 
interaction and altering its posttranslational phosphorylation form. The application of 
calcineurin inhibitor resulted in an increasing level of phosphorylated form of Osterix. 
Nevertheless, it remains unclear how the phosphorylation of Osterix occurs and modulates 
its function. 
3. Transcriptional control of osteochondrogenesis 
In mammals, most skeletal elements are formed through endochondral bone formation, 
which is characterized by the initial formation of cartilage molds from mesenchymal 
condensations and their subsequent replacement by bones. Two groups of transcription 
factors that control the key steps of chondrocyte differentiation have been identified: Sox 
(sex reversal Y-related high-mobility group box protein) and Runt families. 
Natural chondrogenesis is initiated by Indian hedgehog signaling and associated with the 
expression of the major transcription factor Sox9 that controls downstream genes involved 
in chondrogenesis, and promoting cells to produce cartilage-specific extracellular matrix 
including collagen type X, collagen type II alpha 1, cartilage oligomeric matrix protein and 
proteoglycans. In chondrogenesis, Sox9 requires the activity of two other Sox family 
members: Sox6 and the large isoform of Sox5. Runt family members has also ability to drive 
chondrocyte differentiation. The stages of chondrocyte differentiation are regulated by a 
complex series of signaling molecules and transcription factors but also by paracrine factors 
such as TGF-, BMPs, FGFs, and Wnts. 
3.1 Sox protein and chondrocyte commitment 
Sox9 is considered the master protein that control chondrogenic lineage commitment. Role 
of Sox9 in chondrogenesis was first demonstrated in a human genetic disease campomelic 
dysplasia. This disease is caused by heterozygous inactivating mutations in and around the 
Sox9 gene and is characterized by hypoplasia of all endochondral skeletal elements. 
Sox9 belongs to a large family of SRY (sex-determination factors) transcriptional regulators 
which are characterized by a high mobility group DNA-binding domain (HMG-box). This 
domain preferentially binds CA/TTTGA/TA/T sequence in vitro (Han & Lefebvre, 2008). 
www.intechopen.com
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Sox9 binds to DNA within the minor groove of double helix. Chondrocyte-specific genes 
(i.e.: collagen type II alpha1-Col2a1, collagen type XI alpha2-Col11a2) contain Sox9-binding 
sites, mutations in this DNA region abolished DNA binding of Sox9 inactivated these gene 
in vivo and in vitro. Sox9 is required during sequential steps of the chondrocyte 
differentiation pathway. In skeletal development, Sox9 is expressed during the formation of 
mature cartilage and mesenchymal condensation in endochondrial ossification except 
hypertrophic chondrocytes. Abnormal expression of Sox9 leads to severe skeletal disorders 
like skeletal dysmorphology syndrome or campomelic dysplasia. It was shown in 
experiments in mouse chimeras using Sox9-double null embryonic stem cells that 
development of cartilages gene is not carried out without active Sox9. On the other hand, 
forced expression of Sox9 in non-chondrogenic cells leads to the expression of chondrogenic 
markers, such as collagen type II alpha1 (Col2a1), aggrecan (Acan) and cartilage oligomeric 
matrix protein (Comp). Interestingly, overexpression of Sox9 in the cartilage causes a 
decrease in chondrocyte proliferation and a delay in bone development. This decrease in 
proliferation may result from binding of Sox9 to β-catenin, the essential component of the 
canonical Wnt signaling pathway. Along with the observation, overactivation or deletion of 
β-catenin in chondrocytes resulted in severe skeletal dysplasias. The expression and 
function of Sox9 is not restricted to chondrogenesis, suggesting that this regulator may 
cooperate with other factors in various/different cellular processes. The activity of Sox9 is 
regulated by a number of intracellular factors. The function of Sox9 may be modulated by 
phosphorylation cAMP-dependent protein kinase A by parathyroid hormone-related 
peptide signaling pathway (PTHrP). It is, therefore, possible that Sox9 mediates part of 
PTHrP action to regulate hypertrophic differentiation (Zhao et al., 2009). 
Other Sox genes necessary for cartilage formation include Sox5 and Sox6. They are 
expressed downstream of Sox9 from the prechondrocyte stage and later remain coexpressed 
with Sox9. Sox5 gene is highly similar to Sox6, and the two proteins share 50% homology 
with Sox9 in the Sox domain but not in remaining domains. The expression of Sox5 and 
Sox6 requires Sox9. Roles of Sox5 and Sox6 in chondrogenic differentiation were 
demonstrated in genetically manipulated mice. Single Sox5 or Sox6 knock-out mice mutants 
are born with relatively small skeletal defects, whereas double Sox5/Sox6 mutants exhibit a 
lack of cartilage and endochondral bone formation, becouse Sox5, Sox6, with Sox9 form a 
trio of transcription factors needed and sufficient for chondrogenesis. Sox5 and Sox6 may 
form homo- and heterodimers with each other, which bind much more efficiently to pairs of 
HMG-box binding sites than to single binding sites. Sox5 and Sox6 do not contain any 
domain that allows for transactivation or -repression of genes transcription and may thus 
act only to facilitate the organization of transcriptional complexes. Yu Han and Veronique 
Lefebvre data suggest a new model for the chondrogenic action of the Sox trio: 
"mesenchymal cells and prechondrocytes express chondrocyte markers at low or 
undetectable levels because Sox9 has a limited ability to bind to the cartilage enhancers of 
these genes in the absence of Sox5/Sox6. By inducing Sox5 and Sox6 expression in overtly 
differentiating chondrocytes, Sox9 gives itself the potential to upregulate its own activity as 
Sox5/Sox6 now binds to distinct sites on the enhancers and thereby secures Sox9 binding to 
its recognition site" (Han & Lefebvre, 2008). Only combination of all factors: Sox5, Sox6, and 
Sox9 successfully induce chondrogenic differentiation in vivo. Chondrogenic system in vitro 
via the changes in combination of the three Sox protein levels provide a new chondrogenic 
differentiation model, which may help us to better understand the mechanism of this 






3.2 Role of Runt family members in osteochondrogenesis 
The Runt family of DNA-binding transcription factors regulates cell fate determination in a 
number of tissues and has been shown to play an essential role in the differentiation of 
osteoblasts. They play a major role at the late stage of chondrocyte differentiation: in 
hypertrophic and maturating chondrocytes. In addition to osteoblasts, Runx2 is expressed in 
the lateral mesoderm, mesenchymal condensations, and chondrocytes. Runx3, which is 
another Runt family transcription factor, is engaged in the terminal differentiation of 
chondrocytes (Komori, 2005). Chondrocytes divide and produce a characteristic matrix but 
then stop dividing, change the matrix they synthesize, and become quite large 
(hypertrophic). Runx2 and, to a lesser extent, Runx3, are the major transcription factors 
controlling the crucial steps of osteochondrogenesis. Mice missing Runx2 show a defect in 
chondrocyte maturation, with lack of hypertrophic chondrocytes in many bones, and mice 
missing both Runx2 and Runx3 completely lack chondrocytes. The activity of Runx2 and 
Runx3 is modulated through the interactions with other factors. During chondrogenesis, 
expression of Runx2, is abolished in cells with heterozygous mutations in and around Sox9 
(Akiyama et al., 2005). Dlx5 and Dlx6 proteins cooperate with Runx2 in activation of 
hypertrophic gene expression as they can physically interact with Runx2 and control 
chondrocyte hypertrophy in vivo and in vitro (Chin et al., 2007). Karsenty group results 
suggest that Runx2, in addition to promoting hypertrophy through its expression in 
chondrocytes, negatively regulates hyperthrophy by acting in the perichondrium thereby 
providing an additional level of control in order to coordinate chondrocyte maturation and 
osteoblastogenesis (Hinoi et al., 2006). By using small interfering RNA-mediated knock-
down of Bapx1 (also know as Nkx3.2) in cultured chondrocytes an increase in Runx2 
expression was shown, what indicate that Bapx1 act as a negative regulator of chondrocyte 
maturation (Hartman, 2009).  
3.3 c-Maf protein 
Chondrocyte differentiation in the growth plate is an important process for the longitudinal 
growth of endochondral bones. Sox9 and Runx2 are the most often-studied transcriptional 
regulators of the chondrocyte differentiation processes, but the importance of additional 
factors is also becoming apparent. One such factor is c-Maf. It belongs to a subfamily of the 
basic ZIP (bZIP) transcription factor superfamily, which act as key regulators of tissue-
specific gene expression and terminal differentiation in many tissues. This regulator is low 
expressed in immature proliferating chondrocytes but high expressed in late hypertrophic 
and terminal chondrocytes, making it a candidate for controlling terminal differentiation. 
There is increasing evidence that c-Maf and its splicing variant Lc-Maf play a role in 
chondrocyte differentiation in a temporal-spatial manner. Various types of abnormalities in 
endochodrnal ossification or chondrocytic differentiation are caused by abnormalities 
concerning target genes regulated by c-Maf and Lc-Maf as well as lack of c-Maf itself (as 
phenotype of mice lacking c-Maf show) (Hong et al., 2011). Although the differential 
expression patterns of c-Maf and Lc-Maf during chondrogenesis were described, the 
functional differences between them are still unknown.  
c-Maf can form homodimers as well as heterodimers with other transcription factors. c-Maf 
binding site was identified: two 13- and 14-base pair palindrome sequences, 
TGCTGACTCAGCA and TGCTGACGTCAGCA (Kataoka et al., 1994). 
Studies of the roles of Maf proteins in chondrocyte differentiation and cartilage are under 
way, as is the identification of genes directly regulated by c-Maf. A causative role for c-Maf 
will require more hard evidence from direct experiments. 
www.intechopen.com
 
Transcriptional Control of Osteogenesis 
 
9 
4. Tissue-nonspecific factors for bone formation 
During the development of multicellular organisms, cell fate specification is followed by the 
sorting of different cell types into distinct domains where the different tissues and organs 
are formed. It has been shown that the formation and differentiation of tissues and organs 
during embryogenesis is regulated by the activation of a number of factors, which cannot be 
considered skeletal specific, although they are thought to play a key role in the 
differentiation and maturation of the osteoblast phenotype, and were observed in tissues 
that undergo both membranous and endochondral ossification. Alterations in functions of 
various other non-bone-specific transcription factors have been also demonstrated to affect 
osteoblastic differentiation and function. Among the many factors essential for 
organogenesis, and required for skeletal development are: bone morphogenetic proteins 
(BMPs), Wingless-type (WNT), homeobox genes HOX/HOM, DLX, MSX, ZPA (regulating 
the activity of tissue polarity, zone polarizing activity), FGF (fibroblast growth factor), Sonic 
and Indian Hedgehog (Shh and Ihh, respectively) (Witkowska-Zimny et al., 2010).  
4.1 Bone morphogenetic proteins 
Bone Morphogenetic Proteins (BMPs) belonging to the superfamily of transforming growth 
factors  (TGF-) are important regulators involved in the differentiation process of forming 
tissues and organs during embryogenesis, including growth and differentiation of 
mesenchymal stem cells into osteogenic cells (Phimphilai et al., 2006). BMPs also play a key 
role in tissue regeneration in the post-embryonic period. Several proteins belonging to the 
group of BMPs have been described, of which BMP2, BMP4, BMP7 are acknowledged as 
osteogenic BMPs since they have been demonstrated to induce osteoblast differentiation in a 
variety of cell types. BMPs, which function by activating intracellular SMAD proteins and 
kinase signaling cascades (MAP, ERK PI3-K/AKT) are involved in the expression of 
multiple target genes (Osyczka et al., 2005). BMPs signals directly correspond to the early 
embryogenesis proteins containing homeodomain (called homeodomain proteins) involved 
in the development of the skeleton (HoxA10, Dlx3) (Hassan et al., 2006). Furthermore, the 
transcription factor of early ostoblastogenesis, Runx2, is induced in response to the presence 
of BMP2, by a SMAD-dependent signal transduction pathway (Phimphilai et al., 2006). 
Leong and colleagues demonstrated that palmitoylation was involved in the BMP2-
dependent pathway. The inhibition of palmitoylation reduce osteoblast differentiation and 
mineralization, but had no effect on cell proliferation (Leong et al., 2009). This study was the 
first one to show that protein palmitoylation plays an important role in osteoblast 
differentiation and function.  
BMPs also play a role in many stages of chondrogenic differentiation, initiating 
chondroprogenitor cell determination and differentiation of precursors into chondrocytes, 
and also at the stage of chondrocyte maturation and terminal differentiation (Pizette & 
Niswander, 2000; Retting et al., 2009). In addition, signalling through the BMP receptors is 
required for the maintenance of the articular cartilage in postnatal organisms (Rountree et 
al., 2004). Moreover, BMPs promote cell death and apoptosis of chondrocytes (Zou & 
Niswander, 1996). 
Despite numerous studies, the regulatory pathway dependent on BMP is still not fully 
understood. Although the molecular mechanisms of signal transduction by BMPs are not 
known, recombinant human BMP2 and BMP7 have been successfully used in clinical 







WNTs are secreted glycoproteins involved in the regulation of embryonic development, as 
well as in the proliferation and differentiation of many tissues, including bone. WNT signal 
transmission in the cell occurs via various WNT-dependent pathways, which are always 
activated by binding WNT proteins to the endothelial Frizzled receptor (Fzd) and its 
coreceptor (Mbalaviele et al., 2005). Activation of a specific pathway depends on the type of 
WNT ligand and the current conditions within the cell. Gain- or loss-of-function studies in 
mice have revealed the function of various component of the pathway. To date 19 WNT 
ligands and 10 different subtypes of Fzd receptors have been detected. The many players in 
the WNT cascade hamper the precise elucidation of the mechanism by which WNT 
signaling specificity is achieved. By far the best characterized cascade is the canonical 
signaling pathway. It has been reported that binding the WNT to the endothelial Fzd 
receptor and LRP-5/6 protein (lipoprotein-related protein 5 and 6) on the surface of 
osteoblast progenitor cells, involves the stabilization of the central player in the canonical 
WNT pathway - -catenin, and regulation of multiple transcription factors. The level of 
-catenin increases in the cytoplasm, which results in its transport to the nucleus and 
activation ofosteoblast differentiation genes expression. This process is mediated by 
transcriptional factors, including Runx2 and Osterix. An appropriate level of the canonical 
Wnt signalling is crucial for chondrogenesis, demonstrated by the abnormal growth plate 
phenotype in mice harbouring inactivated β-catenin in chondrocytes (Ryu et al., 2002). 
-catenin is highly expressed in mesenchymal cells committed to the chondrocytic lineage 
but down-regulated at the stage of early chondrogenic differentiation, upon up-regulation 
of Sox9 (Akiyama et al., 2004). Sox9 interacts with -catenin and enhances its 
phosphorylation and subsequent degradation. Wnt signalling is again up-regulated during 
hypertrophy and promotes chondrocyte hypertrophy and endochondral ossification (Hill et 
al., 2005). WNT/-catenin signaling is also important for mechanotransduction and fracture 
healing (Westendorf et al., 2004; Chen et al., 2007). 
4.3 HOX – homeobox proteins 
HOX protein family, encoded by a subclass of homebox genes, belongs to the regulators 
controlling the process of embryogenesis in vertebrates. These homeobox transcriptional 
factors are capable of binding to specific nucleotide sequences on DNA where they either 
activate or repress genes. The expression of the HOX genes in the developing area is 
temporally and spatially dynamic. They are critical for proper formation of skeletal tissue. 
HoxA and HoxD serve in a dose-dependent manner to regulate the size of specific cartilage 
elements. A surprising finding was that loss of these genes does not interfere the 
chondrocyte proliferation and differentation, but the growth of the individual elements is 
not established properly. Therefore, in controlling osteochondrogenesis they act later to 
regulate longitudinal growth of skeletal elements (Boulet & Capecchi, 2004). 
HoxA10 and other homeobox genes responsible inter alia for osteoblastogenesis also 
participate in the regulation of cell proliferation, differentiation and maturation of 
osteoblasts in the process of modeling and regeneration of bone tissue in adult organism 
(Zakany et al., 2007). Research conducted in the last two years has shown the dependence of 
Runx2 gene expression and Runx2-dependent genes (encoding osteocalcin, alkaline 
phosphatase, bone sialoprotein) on HoxA10. It also showed that HoxA10, both directly and 
independently of Runx2, regulates the transcription of certain genes during 
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osteoblastogenesis. Two mechanisms of HoxA10 action have been proposed: as a 
component of the BMP2 signaling cascade, prior to Runx2 involvement in the induction of 
genes as a factor osteoblastogenesis, and as a chromatin modifier in the promoter regions of 
genes specific to bone tissue. Combinatory mechanisms are operative for a regulated 
transcription of osteoblast genes through the diversification of sequence-specific activators 
and repressors that contribute to patterns of gene expression and the multistep process of 
programming involved in bone formation.  
4.4 DLX – Distal-less homeodomain proteins 
DLX is a family of transcription regulators containing the homeobox domain, which are 
activated by a BMP2 signal. Dlx3 expression is synchronized with the stages of osteoblast 
growth and induced by BMP2 (Hassan et al., 2006). An overexpression of Dlx3 in osteoblast 
progenitor cells changes the expression of the differentiation markers: type I collagen, 
osteocalcin and alkaline phosphatase. It has been demonstrated that two members of this 
family, Dlx3 and Dlx5, up-regulate the endogenous expression of Runx2. Like HoxA10, Dlx3 
and Dlx5 may participate in ostoblastogenesis through the activation of Runx gene 
expression, but also directly through other genes, independently of Runx2. It has been 
demonstrated that Dlx3 and Dlx5 regulate the synthesis of Runx2, but at different stages of 
the osteoblast differentiation process: Dlx3 in the early stages of osteoblastogenesis, while 
Dlx5 in mature osteoblasts (Hassan et al., 2009). DLX proteins may bind to Runx2 promoter 
region, but only after the removal of another homeobox protein, MSX (mesh-less 
homeodomain), which acts as a repressor. Dlx3 and Dlx5 binding sites next to Runx2 
binding site have been identified in the promoter region of alkaline phosphatase and 
osteocalcin genes. However, it has been shown that the process of bone tissue differentiation 
occurs in mutants without the Dlx5 gene. This suggests that the Dlx5 protein acts as a 
regulator of expression in the multiprotein activation complex and not as the main 
transcription activator of genes involved in the differentiation of the osteogenic lineage 
(Samee et al., 2008). The specific regulation mechanism of Runt gene expression, alongside 
with other Runx2-dependent genes with the participation of several classes of homeotic 
genes, has been suggested in a few works by Jane B. Lian team (Hassan et al., 2006, 2009). 
4.5 MSX proteins 
Vertebrate Msx are homeobox-containing genes that bear homology to the Drosophila muscle 
segment homeobox gene. The mammalian Msx gene family consists of three members, 
named Msx1, Msx2, and Msx3. Msx3 is expressed only in the dorsal neural tube, whereas 
Msx1 and Msx2 are widely expressed in many organs during embryonic development. Msx 
proteins interact with other homeodomain proteins to regulate transcription. Heterodimers 
formed between Msx and other homeodomain proteins such as Dlx2, Dlx5, Lhx2 and Pax3 
result in mutual functional antagonism in vitro. Msx1 and Msx2 are among the critical 
factors involved in osteoblastogenesis. Null mutation of Msx2 leads to a number of defects 
in the construction of the skeleton especially in craniofacial region. Loss-of-function and 
gain-of-function studies show that in mice as in humans Msx1 and Msx2 are required for 
normal craniofacial morphogenesis (Alappat et al., 2003). They play a role in crucial 
processes during limb morphogenesis. Mice homozygous for a null mutation in either Msx1 
or Msx2 do not display abnormalities in limb development. By contrast, Msx1; Msx2 double 






downstream targets of BMP signaling in the limb. At early stages, Msx1 and Msx2 are 
expressed in nearly identical patterns that overlap significantly with BMP2, BMP4 and 
BMP7.  
An antagonistic role of Msx2 has been demonstrated in relation to Dlx5 during osteoblast 
proliferation and differentiation. Dlx5 is activated in the later stages of osteoblastogenesis, 
which correlate with increasing levels of proteins characteristic of terminally differentiated 
osteoblasts, such as osteocalcin, while Msx2 adversely affect these processes. On the basis of 
these studies, it has been suggested that Msx2 stimulates the process of cell proliferation and 
inhibits cell differentiation. Several models for the Msx2 and Dlx5 relationship have been 
proposed. In the first model, Runx2-Msx2 forms a complex that deactivates expression of 
Runx2 and Runx2-dependent genes. With the increasing levels of Dlx5, a Dlx5-Msx2 
complex is formed and free Runx2 protein can in consequence activate specific genes. In the 
second model for Dlx5 and Msx2 interaction, proteins compete for binding to common 
binding sites in the promoter region of specific genes and they also regulate each other at 
the transcriptional level. In both cases a balance between the levels of Msx2 and Dlx5 may be 
critical for osteoprogenitor cell proliferation and differentiation (Lallemand et al., 2005). It is 
certain that, Msx with other morphogenes and transcription factors build a complex cellular 
network that control the development and behavior of cells. It would be of great interest to 
identify the direct target genes of Msx proteins in vivo and their associated cellular processes 
including proliferation, apoptosis, cell adhesion and migration during organogenesis. 
4.6 Hedgehog proteins 
Hedgehog (Hh) is evolutionarily conserved family in vertebrates, which include Sonic (Shh), 
Indian (Ihh), and Desert (Dhh) hedgehogs that control numerous aspects of development: 
cell growth, survival, and differentiation, and pattern almost every aspect of the vertebrate 
body plan. Dhh expression is largely restricted to gonads. Ihh is specifically expressed in a 
limited number of tissues, including primitive endoderm, gut and prehypertrophic 
chondrocytes in the growth plates of bones. Shh is the most broadly expressed mammalian 
Hh signaling molecule. During early vertebrate embryogenesis, Shh expressed in midline 
tissues affects skeletal development and most epithelial tissues. The use of a single 
morphogen for such a wide variety of functions is possible because cellular responses to Hh 
depend on the type of responding cell, the amount of Hh received, and the time cells are 
exposed to it (Varjosalo & Taipale, 2008). During skeletogenesis, Shh and Ihh provide 
positional information and initiate or maintain cellular differentiation programs regulating 
the formation of cartilage and bone. Malfunction of the Hh signaling network can cause 
severe skeletal disorders. 
4.6.1 Sonic hedgehog 
Shh signaling acts to initiate an osteogenic program of mesenchymal cells. The human Shh 
has three exons that encodes a 462 amino acid polypeptide. The protein is synthesized as a 
precursor molecule that undergoes cleavage of a signal peptide and then autoproteolytic 
cleavage. This reaction mediated by cholesterol leads to a 19 kDa N-terminal product (Shh-
N) with the signalling domain and a C-terminal product of 25 kDa (Shh-C) possessing the 
cleavage domain closely associated with cholesterol transferase activity. The Shh is highly 
conserved among vertebrates. For example, there is 92.4% identity between human and 
mouse Shh proteins. Increased Hh signaling promotes osteogenesis in various bone-forming 
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cells in vitro. The stimulatory action of Shh on osteogenic differentiation was already 
reported in few studies, suggesting a close interaction between Shh and BMP-2 or 
parathyroid hormone-related peptide (Yuasa et al., 2002.) Shh has been shown to play a key 
role in patterning of the limb, i.e. misregulation of Shh results in severe limb abnormalities. 
Hence, Shh is required for proper ZPA (regulating the activity of tissue polarity, zone 
polarizing activity) signaling and anterior/posterior limb formation (Hill, 2007; Towers et 
al., 2008, James et al., 2010). 
4.6.2 Indian hedgehog 
Growth and differentiation of the endochondral skeleton relies on a complex interplay 
among different signaling factors to regulate the orderly morphogenesis of the skeleton. 
Among these, Ihh appears to play a central role in coordinating chondrocyte proliferation, 
chondrocyte differentiation and osteoblast differentiation. During endochondral bone 
development, Ihh is synthesized by chondrocytes leaving the proliferative pool 
(prehypertrophic chondrocytes) and by early hypertrophic chondrocytes. Ihh is a master 
regulator of both chondrocyte and osteoblast differentiation during endochondral bone 
formation.  
Ihh mutants show: (i) reduced chondrocyte proliferation; (ii) initially delayed, then 
abnormal chondrocyte maturation, and (iii) absence of mature osteoblasts. St-Jacques and 
coworkers suggest a model in which Ihh coordinates diverse aspects of skeletal 
morphogenesis through parathyroid hormone-related peptide dependent and independent 
processes (St-Jacques et al., 1999). Mouse Ihh cDNA encodes a 411 amino acids polypeptide 
with a predicted 27 amino acids signal peptide. After the post-translational modification 
arises a 19 kDa lipid-modified protein. At the cell surface, Ihh activity is mediated by 
binding to the transmembrane receptor, and signaling through the transmembrane G-
protein coupled receptor. Hedgehogs, including Ihh are important signaling molecules 
during embryonic development and are highly conserved within and across species. Mouse 
and human Ihh share 100% amino acid identity of the signaling domain. 
4.7 Zinc finger protein: PLZF and Zfp521 
Zinc finger proteins are believed to be one of the most common classes of proteins in humans 
(approx. 3-4% of human genes encode proteins containing zinc finger domains). One of 
previously described osteoblastogenesis factor – Osterix also belong to this protein type. 
Promyelocytic leukaemia zinc finger protein (Zinc finger protein 145, PLZF) belongs to the 
family of Krüppel-like zinc finger proteins. It is a transcriptional repressor involved in cell 
cycle control and has been implicated in limb development, differentiation of myeloid cells, 
and spermatogenesis. So far little is known about the regulation of PLZF expression. 
PLZF is one of the highly expressed genes during in vitro osteoblastic differentiation in 
many human cell types. Small interfering RNA-mediated gene silencing of PLZF results in a 
reduction of osteoblast-specific genes expression such as alkaline phosphatase, collagen type 
1, osteocalcin and even Runx2 genes. These findings indicate that PLZF plays important 
roles in early osteoblastic differentiation as an upstream regulator of Runx2. Because the 
expression of PLZF was unaffected by the addition of bone morphogenetic protein 2 in vitro, 
it may indicate that PLZF acts independently of the BMP signaling pathway (Ikeda et al., 







Another regulator from Kruppel-like zinc finger protein family associated with osteogenesis 
is Zfp521. Zfp521 is expressed in osteoblast precursors, osteoblasts and osteocytes, as well as 
chondrocytes. Forced expression of Zfp521 in osteoblasts in vivo increases bone formation 
and bone mass. In contrast, overexpression of Zfp521 in vitro antagonizes, while knockdown 
favors, osteoblast differentiation and nodule formation. Zfp521 binds to Runx2, repressing 
its transcriptional activity (Wu et al., 2009). The balance between Zfp521 and Runx2 may 
therefore contribute to the regulation of osteoblast differentiation and bone formation. 
5. MicroRNAs in skeletal development 
One of the first steps in understanding of cell determination requires ascertaining which 
particular genes are activated in a particular cell, either temporarily or continuously. 
Microarrays technology are used as a tool for quantitative expression analysis of many gene 
transcripts in parallel as well as study expression of small non-coding microRNAs that 
repress mRNA translation and thereby regulate differentiation and development. Post-
transcriptional regulation by non-coding RNA molecules has been discovered to be an 
important mechanism to control cellular differentiation, also during bone formation. An 
increasing number of miRNAs have been identified to regulate osteoblast differentiation. 
They promote bone formation by targeting negative regulators of osteogenesis or negatively 
regulate osteoblastogenesis by targeting important osteogenic factors.  
Among many miRNA negatively regulating osteogenesis are Runx2-targeting miRNAs: 
miR-23a, miR-30c, miR-34c, miR-133a, miR-135a, miR-137, miR-204, miR-205, miR-217, and 
miR-338 (Zhang et al., 2011a, 2011b). They significantly impede osteoblast differentiation, 
and their effects can be reversed by the corresponding anti-miRNAs. 
Only a few miRNAs have been identified to specifically regulate chondrogenesis and 
cartilage homeostasis: miR-140 and miR-199 as negative regulators and miR-675 as a 
positive regulator (Miyaki et al., 2009; 2010;). miR-675, whose expression is upregulated by 
Sox9, positively regulates chondrocyte specific gene i.e. Col2a1, and in this way promotes 
chondrogenesis (Dudek et al., 2010; Lin et al., 2009). 
6. Conclusion 
Bone is a highly dynamic tissue, which is regulated by tissue-specific transcription factors, 
as well as by the number of homeotic genes, active both during the organization of tissue 
and organs in the embryonic period as well as in mature bone. The most important factors 
for osteogenesis are compiled and briefly overview in the Table 1.  
Transcriptional regulators control the expression of target genes by the interaction with 
cofactors, coactivators, chromatin remodelling complexes and finally with the general 
transcriptional machinery. Their participation in the regulation of bone formation process is 
complex and require further experimental work to provide understanding of their role and 
elucidate interactions with other factors of signal cascades. Cellular balance between various 
regulatory proteins is extremely important. Many studies have been conducted using 
murine or human cell lines, which are often tumor cell lines e.g. MG63 – human 
osteosarcoma line. The regulatory pathways and routes of signal transduction in these 
experimental systems may not correspond to those occurring in healthy human bone cells. 
Therefore, it is important to enhance our knowledge about proliferation, differentiation and 
regeneration of bone based on in vitro and in vivo studies of normal human cells in the 
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context of natural tissue. From a biomedical point of view, identifying an important 
regulators of bone formation and regeneration in humans has raised the possibility that 
manipulating its expression, function, or signalling pathway could have a major therapeutic 
impact in identifying new targets and opening new avenues for the treatment of bone 
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This book provides an in-depth overview of current knowledge about Osteogenesis, including molecular
mechanisms, transcriptional regulators, scaffolds, cell biology, mechanical stimuli, vascularization and
osteogenesis related diseases. Hopefully, the publication of this book will help researchers in this field to
decide where to focus their future efforts, and provide an overview for surgeons and clinicians who wish to be
directed in the developments related to this fascinating subject.
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